Replies to post #9598 on Rich Pharmaceuticals Inc. (fka RCHA)

[badshah]

"This approval gives the Company an immediate go ahead to start patient enrollment for a Phase 1/2 study using Rich Pharmaceuticals' lead compound RP-323 in clinical trials."

This does not look like a safety trial ???? actual humans to be involved ???